Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print

Industry News

Related Searches:

Filter by:

May 30, 2008
Catalent Pharma Solutions is now offering warehousing and worldwide logistics solutions for storage, distribution, management, and the fulfillment of compliance requirements. The company's logistics services provide for short- or long-term storage in…   Read More »
May 29, 2008
Bristol-Myers Squibb will acquire Kosan Biosciences, a cancer therapeutics company, for approximately $190 million in cash. The acquisition adds two classes of anticancer agents to BMS's pipeline, novel Hsp90 (heat shock protein 90) inhibitors and ep…   Read More »
May 28, 2008
ImmunoGen, Inc. has selected Cytovance Biologics for process development, cell banking and cGMP manufacturing of a proprietary ImmunoGen antibody.     Cytovance will use its 44,000-sq.-ft., multi-product cGMP production facility in…   Read More »
May 23, 2008
DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official…   Read More »
May 21, 2008
Daiichi Sankyo Co., Ltd. has entered into an agreement to acquire U3 Pharma AG, a privately held German biotechnology company focusing on antibody research for the treatment of cancer. Daiichi Sankyo will purchase all of the stock and make a one-time…   Read More »
May 21, 2008
Almac Clinical Technologies, a division of the Almac Group, has signed a record $12 million worth of new studies within the past several weeks, including a global mega-study involving almost 20,000 patients.     Almac Clinical Techn…   Read More »
May 20, 2008
Oso Biopharmaceuticals Manufacturing, LLC has purchased the Albuquerque, NM-based sterile injectables manufacturing business of Catalent Pharma Solutions. Terms of the transaction were not disclosed.     The unit provides cGMP glass…   Read More »
May 16, 2008
Invitrogen Corp. has created a new business unit in cell therapy. The field of cell therapy offers potential for new, novel therapies in fields such as wound care, neurological and immune disorders, and cardiovascular diseases, according to the compa…   Read More »
May 14, 2008
West Analytical Services LLC has introduced a testing platform to help mitigate the risks associated with testing pulmonary and nasal drug products and their delivery devices. The company’s analytical services for pulmonary and nasal drug produ…   Read More »
May 13, 2008
HollisterStier Laboratories has completed the construction of a full-service 6,000-sq.-ft. lab  that includes analytical testing services with an analytical chemistry department. The lab is part of the company’s $42 million, 71,000-sq.-ft.…   Read More »
May 13, 2008
Prevalere Life Sciences has opened a new biotechnology lab at its Whitesboro, NY headquarters, enhancing the current 48,000-sq.-ft. facility and housing seven labs. The company transformed unfinished space into a 1,800-sq.-ft. immunoassay lab, where…   Read More »
May 12, 2008
Forest Laboratories and Daiichi Sankyo have terminated their co-promotion agreement for AZOR (amlodipine and olmesartan medoxomil), Daiichi Sankyo's fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine besylate and…   Read More »
May 8, 2008
Enzon Pharmaceuticals, Inc. announced plans to spin off its biotechnology business into an independent company focusing on the development of cancer treatments. Enzon will fund the new company with $150 million, which is expected to provide two to th…   Read More »
May 8, 2008
Quintiles Transnational Corp. has signed an agreement to acquire Eidetics, a privately held consulting firm located in Boston. Eidetics provides research-based market insights and data analytics to support business decision making in drug development…   Read More »
May 6, 2008
Merck plans to reduce the size of its U.S. sales force by 15%, firing 1,200 reps. The move comes in the wake of slowing cholesterol drug sales as well as increased generic competition, according to the company.     "Merck is ta…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On